Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases

Methods in Enzymology

Volumn 400, Issue , 2005, Pages 104-116

  Court, Michael H ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHOL; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANDROSTANOLONE; BILIRUBIN; CODEINE; COLECALCIFEROL; EPIRUBICIN; ESTRADIOL; ETOPOSIDE; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; IMIPRAMINE; LAMOTRIGINE; LORAZEPAM; MORPHINE; MYCOPHENOLIC ACID; OXAZEPAM; PROPOFOL; PROTEIN GLUCURONOSYLTRANSFERASE 1A3; PROTEIN GLUCURONOSYLTRANSFERASE 1A4; PROTEIN GLUCURONOSYLTRANSFERASE 1A6; PROTEIN GLUCURONOSYLTRANSFERASE 1A9; PROTEIN GLUCURONOSYLTRANSFERASE 2B15; PROTEIN GLUCURONOSYLTRANSFERASE 2B7; ROFECOXIB; SEROTONIN; TAMOXIFEN; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ARTICLE; DNA POLYMORPHISM; DRUG PROTEIN BINDING; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; ISOENZYME ANALYSIS; MOLECULAR PROBE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

EID: 30144436526     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(05)00007-8     Document Type: Review

References (21)

1. Alkharfy K.M., and Frye R.F. High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes J. Chromatogr. B Biomed. Sci. Appl. 753 2001 303 308
2. Bernard O., and Guillemette C. The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants Drug Metab. Dispos. 32 2004 775 778
3. Court M.H., Duan S.X., Guillemette C., Journault K., Krishnaswamy S., von Moltke L.L., and Greenblatt D.J. Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9 Drug Metab. Dispos. 30 2002 1257 1265
4. Court M.H., Krishnaswamy S., Hao Q., Duan S.X., Patten C.J., von Moltke L.L., and Greenblatt D.J. Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: Specificity and influence of the UGT2B7*2 polymorphism Drug Metab. Dispos. 31 2003 1125 1133
5. Court M.H., Hao Q., Krishnaswamy S., Bekaii-Saab T., Al-Rohaimi A., Von Moltke L.L., and Greenblatt D.J. UDP-Glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver J. Pharmacol. Exp. Ther. 310 2004 656 665
6. Dehal S.S., Gange P.V., Crespi C.L., and Patten C.J. Characterization of a probe substrate and an inhibitor of UDP-glucuronosyltransferase 1A4 activity in human liver microsomes and cDNA-expressed UGT-enzymes Drug Metab. Rev. 33 2001 162 [Abstract].
7. Ebert U., Thong N.Q., Oertel R., and Kirch W. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects Eur. J. Clin. Pharmacol. 56 2000 299 304
8. Fisher M.B., Paine M.F., Strelevitz T.J., and Wrighton S.A. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism Drug Metab. Rev. 33 2001 273 297
9. Fisher M.B., Vandenbranden M., Findlay K., Burchell B., Thummel K.E., Hall S.D., and Wrighton S.A. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: Relationship between UGT1A1 promoter genotype and variability in a liver bank Pharmacogenetics 10 2000 727 739
10. Gagne J.F., Montminy V., Belanger P., Journault K., Gaucher G., and Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38) Mol. Pharmacol. 62 2002 608 617
11. Girard H., Court M.H., Bernard O., Fortier L.C., Villeneuve L., Hao Q., Greenblatt D.J., von Moltke L.L., Perussed L., and Guillemette C. Identification of common polymorphisms in the promoter of the UGT1A9 gene: Evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver Pharmacogenetics 14 2004 501 515
12. Innocenti F., Iyer L., Ramirez J., Green M.D., and Ratain M.J. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7 Drug Metab. Dispos. 29 2001 686 692
13. Kasai N., Sakaki T., Shinkyo R., Ikushiro S., Iyanagi T., Ohta M., and Inouye K. Metabolism of 26,26,26,27,27,27-F(6)-1alpha,23S,25-trihydroxyvitamin D(3) by human UDP-glucuronosyltransferase 1A3 Drug Metab. Dispos. 33 2005 102 107
14. Krishnaswamy S., Duan S.X., von Moltke L.L., Greenblatt D.J., and Court M.H. Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6 Drug Metab. Dispos. 31 2003 133 139
15. Krishnaswamy S., Hao Q., von Moltke L.L., Greenblatt D.J., and Court M.H. Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytrypt-amine) analogs as substrates for udp-glucuronosyltransferase 1a6 Drug Metab. Dispos. 32 2004 862 869
16. Nakajima M., Tanaka E., Kobayashi T., Ohashi N., Kume T., and Yokoi T. Imipramine N-glucuronidation in human liver microsomes: Biphasic kinetics and characterization of UDP-glucuronosyltransferase isoforms Drug Metab. Dispos. 30 2002 636 642
17. Nishiyama T., Ogura K., Nakano H., Ohnuma T., Kaku T., Hiratsuka A., Muro K., and Watabe T. Reverse geometrical selectivity in glucuronidation and sulfation of cis- and trans-4-hydroxytamoxifens by human liver UDP-glucuronosyltransferases and sulfotransferases Biochem. Pharmacol. 63 2002 1817 1830
18. Patten C.J., Code E.L., Dehal S.S., Gange P.V., and Crespi C.L. Analysis of UGT enzyme levels in human liver microsomes using form specific anti-peptide antibodies, probe substrate activities and recombinant UGT enzymes Drug Metab. Rev. 33 2001 165. [Abstract].
19. Turgeon D., Carrier J.S., Levesque E., Hum D.W., and Belanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members Endocrinology 142 2001 778 787
20. Watanabe Y., Nakajima M., Ohashi N., Kume T., and Yokoi T. Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1 Drug Metab. Dispos. 31 2003 589 595
21. Zhang J.Y., Zhan J., Cook C.S., Ings R.M., and Breau A.P. Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism Drug Metab. Dispos. 31 2003 652 658